Equity Profile

BRKR

Bruker Corporation

Health CareLife Sciences Tools & Services$8.6B

May6Wed

Post-Earnings Recap

ReportedQ1-2026Pre-Market6:30 AM EDT

Bruker Corporation Beats on EPS, Stock Up 11.29%

Metric	Actual	Expected	Surprise
EPS	$0.31	$0.23	+33.62%
Revenue	N/A	$796M	N/A

management commentary, guidance changes, and full analysis available with Pro.

Bruker Corporation Beats on EPS, Stock Up 11.29%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$0.31	$0.23	+33.62%
Revenue	N/A	$796M	N/A

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

What It Means

Bruker Corporation's strong earnings per share performance exceeded expectations, contributing to an 11.29% increase in stock price. However, revenue figures were not disclosed, leaving some uncertainty about overall performance. Investors reacted positively to the EPS beat, indicating confidence in the company's profitability.

Company Snapshot

Bruker Corporation (BRKR) operates in the health care sector, specifically in life sciences tools and services. The company develops advanced scientific instruments and analytical solutions that are crucial for research and clinical applications, making it a key player in the growing health care and biotechnology markets.

Key Metrics to Watch

EPS

Earnings per share is a critical measure of profitability and will indicate how well Bruker is managing its costs and generating profits.

$0.23

Revenue

Revenue figures provide insight into the company's sales performance and overall demand for its products and services.

$796M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+4.42%

Avg Stock Reaction

-0.75%

Last Quarter Recap

In Q4 2025, Bruker reported an EPS of $0.59, which was below the expected $0.65, resulting in a significant stock drop of 11.60% the following day. The company has faced challenges in meeting earnings expectations recently.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about Bruker's upcoming earnings, with expectations for a modest EPS of $0.23 and revenue of $796 million. However, the company has struggled to meet or exceed earnings estimates in recent quarters.

Bull Case

If Bruker can exceed the EPS estimate and show strong revenue growth, it could signal a recovery in demand for its products, leading to a positive market reaction.

Bear Case

Conversely, if the company misses expectations again, it could raise concerns about its growth prospects and management's ability to navigate current market challenges.

Key Metrics to Watch

EPS

$0.23

Earnings per share is a critical measure of profitability and will indicate how well Bruker is managing its costs and generating profits.

Revenue

$796M

Revenue figures provide insight into the company's sales performance and overall demand for its products and services.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Bruker achieve an EPS of at least $0.23?

This figure is crucial as it reflects the company's ability to manage costs and generate profits, impacting investor confidence.

What are the revenue figures and growth trends in key product segments?

Understanding revenue performance will provide insights into demand for Bruker's products and overall market health.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may be underestimating Bruker's potential for a turnaround, as recent product launches could drive unexpected revenue growth.

Supporting Evidence

Bruker has a history of beating EPS estimates 63% of the time, suggesting potential for positive surprises.

The options market indicates a significant move, which may reflect investor anticipation of a turnaround.

Recent insider selling could indicate a need for management to reassure investors about future growth prospects.

Key Risk

If revenue from key segments exceeds $825 million, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing Bruker's ability to recover from recent earnings misses and demonstrate growth in a competitive environment.

Bull Confirmed If

An EPS of $0.25 or higher, along with revenue exceeding $825 million, would confirm a strong recovery narrative.

Bear Confirmed If

An EPS below $0.21 and revenue falling short of $769 million would indicate ongoing challenges and could lead to further stock declines.

Pre-Earnings Positioning

Options Market

Implied Move

±10.58%

Historical Avg

±5.2%

Pricing rich

The options market is pricing in a significant potential move in either direction following the earnings report, indicating uncertainty among investors.

Options are pricing ±13.2% while BRKR has averaged ±5.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.9%

30d HV

52.1%

Calls (5K)P/C Ratio: 0.48Puts (7K)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$79,800.00

2,000 sh

1 insider

Net

$79,800.00

Net selling

Most Active Insiders· 1 open-market trade

EXEC VP&PRES BRUKER NANO INC.Munch Mark
$79,800.00

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Bruker beats expectations, history suggests a potential stock increase of around 3.32%, confirming a recovery narrative.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

If Bruker misses expectations, the stock could drop by approximately 5.62%, raising concerns about the company's growth trajectory.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on demand trends for key product lines.
2Any commentary on cost management strategies.
3Insights into competitive positioning in the life sciences market.
4Details on any new product launches or innovations.
5Management's outlook on future growth and market conditions.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a critical measure of profitability and will indicate how well Bruker is managing its costs and generating profits.

$0.23

Revenue

Revenue figures provide insight into the company's sales performance and overall demand for its products and services.

$796M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+4.42%

Avg Stock Reaction

-0.75%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Bruker can exceed the EPS estimate and show strong revenue growth, it could signal a recovery in demand for its products, leading to a positive market reaction.

Bear Case

Conversely, if the company misses expectations again, it could raise concerns about its growth prospects and management's ability to navigate current market challenges.

Key Metrics to Watch

EPS

$0.23

Earnings per share is a critical measure of profitability and will indicate how well Bruker is managing its costs and generating profits.

Revenue

$796M

Revenue figures provide insight into the company's sales performance and overall demand for its products and services.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Bruker achieve an EPS of at least $0.23?

This figure is crucial as it reflects the company's ability to manage costs and generate profits, impacting investor confidence.

What are the revenue figures and growth trends in key product segments?

Understanding revenue performance will provide insights into demand for Bruker's products and overall market health.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may be underestimating Bruker's potential for a turnaround, as recent product launches could drive unexpected revenue growth.

Supporting Evidence

Bruker has a history of beating EPS estimates 63% of the time, suggesting potential for positive surprises.

The options market indicates a significant move, which may reflect investor anticipation of a turnaround.

Recent insider selling could indicate a need for management to reassure investors about future growth prospects.

Key Risk

If revenue from key segments exceeds $825 million, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing Bruker's ability to recover from recent earnings misses and demonstrate growth in a competitive environment.

Bull Confirmed If

An EPS of $0.25 or higher, along with revenue exceeding $825 million, would confirm a strong recovery narrative.

Bear Confirmed If

An EPS below $0.21 and revenue falling short of $769 million would indicate ongoing challenges and could lead to further stock declines.

Pre-Earnings Positioning

Options Market

Implied Move

±10.58%

Historical Avg

±5.2%

Pricing rich

The options market is pricing in a significant potential move in either direction following the earnings report, indicating uncertainty among investors.

Options are pricing ±13.2% while BRKR has averaged ±5.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.9%

30d HV

52.1%

Calls (5K)P/C Ratio: 0.48Puts (7K)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$79,800.00

2,000 sh

1 insider

Net

$79,800.00

Net selling

Most Active Insiders· 1 open-market trade

EXEC VP&PRES BRUKER NANO INC.Munch Mark
$79,800.00

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Bruker beats expectations, history suggests a potential stock increase of around 3.32%, confirming a recovery narrative.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

If Bruker misses expectations, the stock could drop by approximately 5.62%, raising concerns about the company's growth trajectory.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on demand trends for key product lines.
2Any commentary on cost management strategies.
3Insights into competitive positioning in the life sciences market.
4Details on any new product launches or innovations.
5Management's outlook on future growth and market conditions.